Delivery Order SPE2DB25D3404-SPE2DB26FULTQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,354.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare immunization...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,522.46 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a firm fixed price structure and an ultimate completion date of September 30, 2025. This non-set-aside award was issued on September 29, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used in federal medical procurement to support military and...
- The Defense Logistics Agency awarded a delivery order valued at $13,220.22 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease across multiple age groups...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $21,884.70 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease in eligible populations, making this order part of...
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a $24,897 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on September 22, 2025, with completion scheduled for September 23, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion blanket purchase agreement running through December 2026 that enables the company to supply a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20.3K to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents delivery of a pneumococcal vaccine product to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULTQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,217.54 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups, representing a critical pharmaceutical supply for military healthcare programs and other federal medical systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. The IDC enables the company to deliver a vast range of medications, vaccines, specialty drugs, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, positioning the contractor as a key vendor in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 10/22/25 |